Janssen Ad26.COV2.S COVID-19 vaccine: Interim guidance and more

Download from the WHO Digital Library	This interim guidance has been developed based on the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its 15 March 2021 extraordinary meeting for the Janssen Ad26.COV2.S COVID-19 vaccine More information: Janssen Ad26.COV2-S: Vaccine Explainer The J&J COVID-19 vaccine: What you need to know How to manage storage and distribution of COVID-19 Vaccine Janssen delivered at -20°C and +2 to +8°C temperatures?